Skip to main content
Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.3900
-0.0146 (-3.61%)
At close: May 14, 2025, 4:00 PM
0.4100
+0.0200 (5.13%)
After-hours: May 14, 2025, 4:17 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
T-cell Therapies
61.00K
Log In
Log In
Log In
Log In
Upgrade
T-cell Therapies Growth
-53.08%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
61.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-53.08%
Log In
Log In
Log In
Log In
Upgrade